China Resources Jiuxin Pharmaceutical

China Resources Jiuxin Pharmaceutical is an active China-based pharmaceutical manufacturing company focused primarily on anti-infective small-molecule products, especially cephalosporin antibiotics and related formulations. The company operates as Shenzhen China Resources Jiuxin Pharmaceutical and appears to be part of the China Resources Sanjiu/China Resources Pharmaceutical group structure. Publicly available records indicate capabilities spanning active pharmaceutical ingredients, finished preparations, production, sales, and testing services, with marketed and approved products including injectable cephalosporins such as ceftriaxone and cefpirome, and a more recent approval for ceftobiprole medocaril sodium for injection. The business is best characterized as a commercial-stage generic/specialty anti-infectives manufacturer rather than a venture biotech with a novel discovery pipeline. It also appears to support manufacturing and prescription-drug operations within the broader China Resources healthcare ecosystem.